LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living ...

Chauhan discussed how two-photon microscopy enables precise, non-invasive monitoring of retinal ganglion cell function in ...

The company notes that the workforce reduction is expected to provide annual cash compensation cost savings of approximately $15 million and offsets additional expenses expected based on the ...

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

New technologies and a proactive mindset are transforming how glaucoma is diagnosed and treated—and redefining what ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

AAV204 is a novel adeno-associated virus (AAV) capsid from the AIM capsid library licensed by Abeona from the University of ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

A new study demonstrates that handheld nanopore sequencers can rapidly identify eye infection pathogens using only a ...

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

In addition to Prevent Blindness’s usual free resources, the organization is providing a dedicated webpage, fact sheets, and ...

Nanoscope Therapeutics formed the Vision Advisory Committee to guide its efforts in retinal care, focusing on retinitis ...